XML 19 R101.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Consolidating Guarantor Financial Information (Details) (USD $)
In Millions
3 Months Ended 6 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Jun. 30, 2011
Jun. 30, 2010
Dec. 31, 2010
Condensed Financial Statements, Captions [Line Items]          
Net sales $ 1,753 $ 1,517 $ 3,342 $ 2,905  
Cost of sales (1,343) (1,214) (2,581) (2,384)  
Gross profit 410 303 761 521  
Selling, general and administrative expenses (140) (124) (268) (248)  
Amortization of intangible assets (17) (15) (33) (30)  
Research and development expenses (25) (17) (48) (35)  
Other (charges) gains, net (18) (6) (15) (83)  
Foreign exchange gain (loss), net (1) 0 0 2  
Gain (loss) on disposition of businesses and assets, net 0 15 0 15  
Operating profit (loss) 209 156 397 142  
Equity in net earnings (loss) of affiliates 46 45 89 94  
Interest expense (57) (49) (112) (98)  
Refinancing expense (3) 0 (3) 0  
Interest income 0 1 1 2  
Dividend income - cost investments 79 72 79 72  
Other income (expense), net 6 (1) 9 5  
Earnings (loss) from continuing operations before tax 280 224 460 217  
Income tax (provision) benefit (75) (61) (117) (41)  
Earnings (loss) from continuing operations 205 163 343 176  
Earnings (loss) from operation of discontinued operations (3) (5) 3 (5)  
Gain (loss) on disposition of discontinued operations 0 0 0 2  
Income tax (provision) benefit from discontinued operations 1 2 (1) 1  
Earnings (loss) from discontinued operations (2) (3) 2 (2)  
Net earnings (loss) 203 160 345 174  
Net (earnings) loss attributable to noncontrolling interests 0 0 0 0  
Net earnings (loss) attributable to Celanese Corporation 203 160 345 174  
Current assets          
Cash and cash equivalents 741 1,081 741 1,081  
Trade receivables - third party and affiliates 1,027   1,027   827
Non-trade receivables, net 239   239   253
Inventories, net 779   779   610
Deferred income taxes 95   95   92
Marketable securities, at fair value 70   70   78
Assets held for sale 0   0   9
Other assets 63   63   59
Total current assets 3,014   3,014   2,668
Investments in affiliates 838   838   838
Property, plant and equipment, net 3,273   3,273   3,017
Deferred income taxes 434   434   443
Other assets 309   309   289
Goodwill 813   813   774
Intangible assets, net 238   238   252
Total assets 8,919   8,919   8,281
Current liabilities          
Short-term borrowings and current installments of long-term debt - third party and affiliates 155   155   228
Trade payables - third party and affiliates 786   786   673
Other liabilities 575   575   596
Deferred income taxes 30   30   28
Income taxes payable 95   95   17
Total current liabilities 1,641   1,641   1,542
Long-term debt 2,893   2,893   2,990
Deferred income taxes 124   124   116
Uncertain tax positions 290   290   273
Benefit obligations 1,321   1,321   1,359
Other liabilities 1,277   1,277   1,075
Shareholders' equity          
Total Celanese Corporation shareholders' equity 1,373   1,373   926
Noncontrolling interests 0   0   0
Total shareholders' equity 1,373   1,373   926
Total liabilities and shareholders' equity 8,919   8,919   8,281
Operating activities          
Net cash provided by (used in) operating activities     316 219  
Investing activities          
Capital expenditures on property, plant and equipment     (151) (78)  
Acquisitions, net of cash acquired     (8) (46)  
Proceeds from sale of businesses and assets, net     5 20  
Deferred proceeds from Ticona Kelsterbach plant relocation     158 0  
Capital expenditures related to Ticona Kelsterbach plant relocation     (114) (151)  
Other, net     (23) (20)  
Net cash provided by (used in) investing activities     (133) (275)  
Financing activities          
Short-term borrowings (repayments), net     (34) (9)  
Proceeds from long-term debt     411 0  
Repayments of long-term debt     (553) (38)  
Refinancing costs     (8) 0  
Proceeds and (repayments) from intercompany financing activities     0 0  
Purchases of treasury stock, including related fees     (13) (20)  
Dividends from subsidiary     0 0  
Dividends to parent     0 0  
Contributions from parent to subsidiary     0 0  
Stock option exercises     17 4  
Series A common stock dividends     (16) (12)  
Preferred stock dividends     0 (3)  
Other, net     (2) 0  
Net cash provided by (used in) financing activities     (198) (78)  
Exchange rate effects on cash and cash equivalents     16 (39)  
Net increase (decrease) in cash and cash equivalents     1 (173)  
Cash and cash equivalents at beginning of period     740 1,254  
Cash and cash equivalents at end of period 741 1,081 741 1,081  
Parent Guarantor [Member]
         
Condensed Financial Statements, Captions [Line Items]          
Net sales 0 0 0 0  
Cost of sales 0 0 0 0  
Gross profit 0 0 0 0  
Selling, general and administrative expenses 0 0 0 0  
Amortization of intangible assets 0 0 0 0  
Research and development expenses 0 0 0 0  
Other (charges) gains, net 0 0 0 0  
Foreign exchange gain (loss), net 0 0 0 0  
Gain (loss) on disposition of businesses and assets, net 0 0 0 0  
Operating profit (loss) 0 0 0 0  
Equity in net earnings (loss) of affiliates 202 160 344 174  
Interest expense 0 0 0 0  
Refinancing expense 0 0 0    
Interest income 0 0 0 0  
Dividend income - cost investments 0 0 0    
Other income (expense), net 0 0 0 0  
Earnings (loss) from continuing operations before tax 202 160 344 174  
Income tax (provision) benefit 1 0 1 0  
Earnings (loss) from continuing operations 203 160 345 174  
Earnings (loss) from operation of discontinued operations 0 0 0 0  
Gain (loss) on disposition of discontinued operations 0 0 0 0  
Income tax (provision) benefit from discontinued operations 0 0 0 0  
Earnings (loss) from discontinued operations 0 0 0 0  
Net earnings (loss) 203 160 345 174  
Net (earnings) loss attributable to noncontrolling interests 0 0 0 0  
Net earnings (loss) attributable to Celanese Corporation 203 160 345 174  
Current assets          
Cash and cash equivalents 1 0 1 0  
Trade receivables - third party and affiliates 0   0   0
Non-trade receivables, net 0   0   0
Inventories, net 0   0   0
Deferred income taxes 0   0   0
Marketable securities, at fair value 0   0   0
Assets held for sale 0   0   0
Other assets 0   0   0
Total current assets 1   1   0
Investments in affiliates 1,348   1,348   903
Property, plant and equipment, net 0   0   0
Deferred income taxes 0   0   0
Other assets 0   0   0
Goodwill 0   0   0
Intangible assets, net 0   0   0
Total assets 1,349   1,349   903
Current liabilities          
Short-term borrowings and current installments of long-term debt - third party and affiliates 0   0   0
Trade payables - third party and affiliates 0   0   0
Other liabilities 0   0   0
Deferred income taxes 0   0   0
Income taxes payable (28)   (28)   (26)
Total current liabilities (28)   (28)   (26)
Long-term debt 0   0   0
Deferred income taxes 0   0   0
Uncertain tax positions 4   4   3
Benefit obligations 0   0   0
Other liabilities 0   0   0
Shareholders' equity          
Total Celanese Corporation shareholders' equity 1,373   1,373   926
Noncontrolling interests 0   0   0
Total shareholders' equity 1,373   1,373   926
Total liabilities and shareholders' equity 1,349   1,349   903
Operating activities          
Net cash provided by (used in) operating activities     0 0  
Investing activities          
Capital expenditures on property, plant and equipment     0 0  
Acquisitions, net of cash acquired     0 0  
Proceeds from sale of businesses and assets, net     0 0  
Deferred proceeds from Ticona Kelsterbach plant relocation     0 0  
Capital expenditures related to Ticona Kelsterbach plant relocation     0 0  
Other, net     0 0  
Net cash provided by (used in) investing activities     0 0  
Financing activities          
Short-term borrowings (repayments), net     0 0  
Proceeds from long-term debt     0 0  
Repayments of long-term debt     0 0  
Refinancing costs     0 0  
Proceeds and (repayments) from intercompany financing activities     0 0  
Purchases of treasury stock, including related fees     (13) (20)  
Dividends from subsidiary     13 26  
Dividends to parent     0 0  
Contributions from parent to subsidiary     0 0  
Stock option exercises     17 4  
Series A common stock dividends     (16) (12)  
Preferred stock dividends     0 (3)  
Other, net     0 0  
Net cash provided by (used in) financing activities     1 (5)  
Exchange rate effects on cash and cash equivalents     0 0  
Net increase (decrease) in cash and cash equivalents     1 (5)  
Cash and cash equivalents at beginning of period     0 5  
Cash and cash equivalents at end of period 1 0 1 0  
Issuer [Member]
         
Condensed Financial Statements, Captions [Line Items]          
Net sales 0 0 0 0  
Cost of sales 0 0 0 0  
Gross profit 0 0 0 0  
Selling, general and administrative expenses 0 0 0 0  
Amortization of intangible assets 0 0 0 0  
Research and development expenses 0 0 0 0  
Other (charges) gains, net 0 0 0 0  
Foreign exchange gain (loss), net 0 0 0 0  
Gain (loss) on disposition of businesses and assets, net 0 0 0 0  
Operating profit (loss) 0 0 0 0  
Equity in net earnings (loss) of affiliates 246 192 424 231  
Interest expense (56) (41) (107) (80)  
Refinancing expense (3) 0 (3)    
Interest income 5 5 11 10  
Dividend income - cost investments 0 0 0 0  
Other income (expense), net 1 (2) 3 (1)  
Earnings (loss) from continuing operations before tax 193 154 328 160  
Income tax (provision) benefit 9 6 16 14  
Earnings (loss) from continuing operations 202 160 344 174  
Earnings (loss) from operation of discontinued operations 0 0 0 0  
Gain (loss) on disposition of discontinued operations 0 0 0 0  
Income tax (provision) benefit from discontinued operations 0 0 0 0  
Earnings (loss) from discontinued operations 0 0 0 0  
Net earnings (loss) 202 160 344 174  
Net (earnings) loss attributable to noncontrolling interests 0 0 0 0  
Net earnings (loss) attributable to Celanese Corporation 202 160 344 174  
Current assets          
Cash and cash equivalents 0 0 0 0  
Trade receivables - third party and affiliates 0   0   0
Non-trade receivables, net 85   85   10
Inventories, net 0   0   0
Deferred income taxes 25   25   25
Marketable securities, at fair value 0   0   0
Assets held for sale 0   0   0
Other assets 2   2   48
Total current assets 112   112   83
Investments in affiliates 4,236   4,236   3,721
Property, plant and equipment, net 0   0   0
Deferred income taxes 13   13   19
Other assets 618   618   614
Goodwill 0   0   0
Intangible assets, net 0   0   0
Total assets 4,979   4,979   4,437
Current liabilities          
Short-term borrowings and current installments of long-term debt - third party and affiliates 1,444   1,444   1,227
Trade payables - third party and affiliates 0   0   0
Other liabilities 74   74   87
Deferred income taxes 0   0   0
Income taxes payable (326)   (326)   (309)
Total current liabilities 1,192   1,192   1,005
Long-term debt 2,410   2,410   2,498
Deferred income taxes 0   0   0
Uncertain tax positions 18   18   17
Benefit obligations 0   0   0
Other liabilities 11   11   14
Shareholders' equity          
Total Celanese Corporation shareholders' equity 1,348   1,348   903
Noncontrolling interests 0   0   0
Total shareholders' equity 1,348   1,348   903
Total liabilities and shareholders' equity 4,979   4,979   4,437
Operating activities          
Net cash provided by (used in) operating activities     0 0  
Investing activities          
Capital expenditures on property, plant and equipment     0 0  
Acquisitions, net of cash acquired     0 0  
Proceeds from sale of businesses and assets, net     0 0  
Deferred proceeds from Ticona Kelsterbach plant relocation     0 0  
Capital expenditures related to Ticona Kelsterbach plant relocation     0 0  
Other, net     0 0  
Net cash provided by (used in) investing activities     0 0  
Financing activities          
Short-term borrowings (repayments), net     0 0  
Proceeds from long-term debt     400 0  
Repayments of long-term debt     (525) (14)  
Refinancing costs     (8) 0  
Proceeds and (repayments) from intercompany financing activities     133 14  
Purchases of treasury stock, including related fees     0 0  
Dividends from subsidiary     113 26  
Dividends to parent     (13) (26)  
Contributions from parent to subsidiary     (100) 0  
Stock option exercises     0 0  
Series A common stock dividends     0 0  
Preferred stock dividends     0 0  
Other, net     0 0  
Net cash provided by (used in) financing activities     0 0  
Exchange rate effects on cash and cash equivalents     0 0  
Net increase (decrease) in cash and cash equivalents     0 0  
Cash and cash equivalents at beginning of period     0 0  
Cash and cash equivalents at end of period 0 0 0 0  
Subsidiary Guarantors [Member]
         
Condensed Financial Statements, Captions [Line Items]          
Net sales 660 551 1,275 1,103  
Cost of sales (472) (428) (908) (858)  
Gross profit 188 123 367 245  
Selling, general and administrative expenses (41) (43) (80) (90)  
Amortization of intangible assets (5) (4) (9) (6)  
Research and development expenses (17) (10) (30) (20)  
Other (charges) gains, net 6 2 25 11  
Foreign exchange gain (loss), net 0 0 0 0  
Gain (loss) on disposition of businesses and assets, net 1 0 1 0  
Operating profit (loss) 132 68 274 140  
Equity in net earnings (loss) of affiliates 27 39 55 66  
Interest expense (9) (10) (21) (19)  
Refinancing expense 0 0 0 0  
Interest income 10 7 19 13  
Dividend income - cost investments 0 0 0 0  
Other income (expense), net (1) 0 (1) (1)  
Earnings (loss) from continuing operations before tax 159 104 326 199  
Income tax (provision) benefit (49) (32) (93) (44)  
Earnings (loss) from continuing operations 110 72 233 155  
Earnings (loss) from operation of discontinued operations (3) (5) 3 (5)  
Gain (loss) on disposition of discontinued operations 0 0 0 2  
Income tax (provision) benefit from discontinued operations 1 2 (1) 1  
Earnings (loss) from discontinued operations (2) (3) 2 (2)  
Net earnings (loss) 108 69 235 153  
Net (earnings) loss attributable to noncontrolling interests 0 0 0 0  
Net earnings (loss) attributable to Celanese Corporation 108 69 235 153  
Current assets          
Cash and cash equivalents 174 383 174 383  
Trade receivables - third party and affiliates 314   314   246
Non-trade receivables, net 1,639   1,639   1,400
Inventories, net 188   188   164
Deferred income taxes 33   33   33
Marketable securities, at fair value 70   70   77
Assets held for sale 0   0   9
Other assets 24   24   33
Total current assets 2,442   2,442   2,090
Investments in affiliates 1,432   1,432   1,413
Property, plant and equipment, net 665   665   650
Deferred income taxes 399   399   404
Other assets 125   125   125
Goodwill 298   298   297
Intangible assets, net 77   77   79
Total assets 5,438   5,438   5,058
Current liabilities          
Short-term borrowings and current installments of long-term debt - third party and affiliates 133   133   137
Trade payables - third party and affiliates 283   283   249
Other liabilities 374   374   385
Deferred income taxes 0   0   0
Income taxes payable 403   403   314
Total current liabilities 1,193   1,193   1,085
Long-term debt 884   884   980
Deferred income taxes 0   0   0
Uncertain tax positions 29   29   28
Benefit obligations 1,189   1,189   1,230
Other liabilities 103   103   123
Shareholders' equity          
Total Celanese Corporation shareholders' equity 2,040   2,040   1,612
Noncontrolling interests 0   0   0
Total shareholders' equity 2,040   2,040   1,612
Total liabilities and shareholders' equity 5,438   5,438   5,058
Operating activities          
Net cash provided by (used in) operating activities     175 (48)  
Investing activities          
Capital expenditures on property, plant and equipment     (63) (32)  
Acquisitions, net of cash acquired     (8) (46)  
Proceeds from sale of businesses and assets, net     1 0  
Deferred proceeds from Ticona Kelsterbach plant relocation     0 0  
Capital expenditures related to Ticona Kelsterbach plant relocation     0 0  
Other, net     (2) (5)  
Net cash provided by (used in) investing activities     (72) (83)  
Financing activities          
Short-term borrowings (repayments), net     (8) 2  
Proceeds from long-term debt     0 0  
Repayments of long-term debt     (1) (1)  
Refinancing costs     0 0  
Proceeds and (repayments) from intercompany financing activities     (133) 19  
Purchases of treasury stock, including related fees     0 0  
Dividends from subsidiary     0 0  
Dividends to parent     (13) (26)  
Contributions from parent to subsidiary     100 0  
Stock option exercises     0 0  
Series A common stock dividends     0 0  
Preferred stock dividends     0 0  
Other, net     (2) 0  
Net cash provided by (used in) financing activities     (57) (6)  
Exchange rate effects on cash and cash equivalents     0 0  
Net increase (decrease) in cash and cash equivalents     46 (137)  
Cash and cash equivalents at beginning of period     128 520  
Cash and cash equivalents at end of period 174 383 174 383  
Non-Guarantors [Member]
         
Condensed Financial Statements, Captions [Line Items]          
Net sales 1,380 1,170 2,611 2,237  
Cost of sales (1,154) (992) (2,205) (1,969)  
Gross profit 226 178 406 268  
Selling, general and administrative expenses (99) (81) (188) (158)  
Amortization of intangible assets (12) (11) (24) (24)  
Research and development expenses (8) (7) (18) (15)  
Other (charges) gains, net (24) (8) (40) (94)  
Foreign exchange gain (loss), net (1) 0 0 2  
Gain (loss) on disposition of businesses and assets, net (1) 15 (1) 15  
Operating profit (loss) 81 86 135 (6)  
Equity in net earnings (loss) of affiliates 35 36 71 69  
Interest expense (9) (11) (19) (23)  
Refinancing expense 0 0 0 0  
Interest income 2 2 6 3  
Dividend income - cost investments 79 72 79 72  
Other income (expense), net 6 1 7 7  
Earnings (loss) from continuing operations before tax 194 186 279 122  
Income tax (provision) benefit (37) (50) (43) (27)  
Earnings (loss) from continuing operations 157 136 236 95  
Earnings (loss) from operation of discontinued operations 0 0 0 0  
Gain (loss) on disposition of discontinued operations 0 0 0 0  
Income tax (provision) benefit from discontinued operations 0 0 0 0  
Earnings (loss) from discontinued operations 0 0 0 0  
Net earnings (loss) 157 136 236 95  
Net (earnings) loss attributable to noncontrolling interests 0 0 0 0  
Net earnings (loss) attributable to Celanese Corporation 157 136 236 95  
Current assets          
Cash and cash equivalents 566 698 566 698  
Trade receivables - third party and affiliates 853   853   672
Non-trade receivables, net 500   500   515
Inventories, net 639   639   484
Deferred income taxes 37   37   34
Marketable securities, at fair value 0   0   1
Assets held for sale 0   0   0
Other assets 53   53   43
Total current assets 2,648   2,648   2,361
Investments in affiliates 545   545   530
Property, plant and equipment, net 2,608   2,608   2,367
Deferred income taxes 22   22   20
Other assets 314   314   389
Goodwill 515   515   477
Intangible assets, net 161   161   173
Total assets 6,813   6,813   6,317
Current liabilities          
Short-term borrowings and current installments of long-term debt - third party and affiliates 220   220   190
Trade payables - third party and affiliates 643   643   515
Other liabilities 496   496   544
Deferred income taxes 30   30   28
Income taxes payable 49   49   39
Total current liabilities 1,438   1,438   1,316
Long-term debt 343   343   346
Deferred income taxes 124   124   116
Uncertain tax positions 239   239   225
Benefit obligations 132   132   129
Other liabilities 1,178   1,178   954
Shareholders' equity          
Total Celanese Corporation shareholders' equity 3,359   3,359   3,231
Noncontrolling interests 0   0   0
Total shareholders' equity 3,359   3,359   3,231
Total liabilities and shareholders' equity 6,813   6,813   6,317
Operating activities          
Net cash provided by (used in) operating activities     141 267  
Investing activities          
Capital expenditures on property, plant and equipment     (88) (46)  
Acquisitions, net of cash acquired     0 0  
Proceeds from sale of businesses and assets, net     4 20  
Deferred proceeds from Ticona Kelsterbach plant relocation     158 0  
Capital expenditures related to Ticona Kelsterbach plant relocation     (114) (151)  
Other, net     (21) (15)  
Net cash provided by (used in) investing activities     (61) (192)  
Financing activities          
Short-term borrowings (repayments), net     (26) (11)  
Proceeds from long-term debt     11 0  
Repayments of long-term debt     (27) (23)  
Refinancing costs     0 0  
Proceeds and (repayments) from intercompany financing activities     0 (33)  
Purchases of treasury stock, including related fees     0 0  
Dividends from subsidiary     0 0  
Dividends to parent     (100) 0  
Contributions from parent to subsidiary     0 0  
Stock option exercises     0 0  
Series A common stock dividends     0 0  
Preferred stock dividends     0 0  
Other, net     0 0  
Net cash provided by (used in) financing activities     (142) (67)  
Exchange rate effects on cash and cash equivalents     16 (39)  
Net increase (decrease) in cash and cash equivalents     (46) (31)  
Cash and cash equivalents at beginning of period     612 729  
Cash and cash equivalents at end of period 566 698 566 698  
Consolidation Eliminations [Member]
         
Condensed Financial Statements, Captions [Line Items]          
Net sales (287) (204) (544) (435)  
Cost of sales 283 206 532 443  
Gross profit (4) 2 (12) 8  
Selling, general and administrative expenses 0 0 0 0  
Amortization of intangible assets 0 0 0 0  
Research and development expenses 0 0 0 0  
Other (charges) gains, net 0 0 0 0  
Foreign exchange gain (loss), net 0 0 0 0  
Gain (loss) on disposition of businesses and assets, net 0 0 0 0  
Operating profit (loss) (4) 2 (12) 8  
Equity in net earnings (loss) of affiliates (464) (382) (805) (446)  
Interest expense 17 13 35 24  
Refinancing expense 0 0 0 0  
Interest income (17) (13) (35) (24)  
Dividend income - cost investments 0 0 0 0  
Other income (expense), net 0 0 0 0  
Earnings (loss) from continuing operations before tax (468) (380) (817) (438)  
Income tax (provision) benefit 1 15 2 16  
Earnings (loss) from continuing operations (467) (365) (815) (422)  
Earnings (loss) from operation of discontinued operations 0 0 0 0  
Gain (loss) on disposition of discontinued operations 0 0 0 0  
Income tax (provision) benefit from discontinued operations 0 0 0 0  
Earnings (loss) from discontinued operations 0 0 0 0  
Net earnings (loss) (467) (365) (815) (422)  
Net (earnings) loss attributable to noncontrolling interests 0 0 0 0  
Net earnings (loss) attributable to Celanese Corporation (467) (365) (815) (422)  
Current assets          
Cash and cash equivalents 0 0 0 0  
Trade receivables - third party and affiliates (140)   (140)   (91)
Non-trade receivables, net (1,985)   (1,985)   (1,672)
Inventories, net (48)   (48)   (38)
Deferred income taxes 0   0   0
Marketable securities, at fair value 0   0   0
Assets held for sale 0   0   0
Other assets (16)   (16)   (65)
Total current assets (2,189)   (2,189)   (1,866)
Investments in affiliates (6,723)   (6,723)   (5,729)
Property, plant and equipment, net 0   0   0
Deferred income taxes 0   0   0
Other assets (748)   (748)   (839)
Goodwill 0   0   0
Intangible assets, net 0   0   0
Total assets (9,660)   (9,660)   (8,434)
Current liabilities          
Short-term borrowings and current installments of long-term debt - third party and affiliates (1,642)   (1,642)   (1,326)
Trade payables - third party and affiliates (140)   (140)   (91)
Other liabilities (369)   (369)   (420)
Deferred income taxes 0   0   0
Income taxes payable (3)   (3)   (1)
Total current liabilities (2,154)   (2,154)   (1,838)
Long-term debt (744)   (744)   (834)
Deferred income taxes 0   0   0
Uncertain tax positions 0   0   0
Benefit obligations 0   0   0
Other liabilities (15)   (15)   (16)
Shareholders' equity          
Total Celanese Corporation shareholders' equity (6,747)   (6,747)   (5,746)
Noncontrolling interests 0   0   0
Total shareholders' equity (6,747)   (6,747)   (5,746)
Total liabilities and shareholders' equity (9,660)   (9,660)   (8,434)
Operating activities          
Net cash provided by (used in) operating activities     0 0  
Investing activities          
Capital expenditures on property, plant and equipment     0 0  
Acquisitions, net of cash acquired     0 0  
Proceeds from sale of businesses and assets, net     0 0  
Deferred proceeds from Ticona Kelsterbach plant relocation     0 0  
Capital expenditures related to Ticona Kelsterbach plant relocation     0 0  
Other, net     0 0  
Net cash provided by (used in) investing activities     0 0  
Financing activities          
Short-term borrowings (repayments), net     0 0  
Proceeds from long-term debt     0 0  
Repayments of long-term debt     0 0  
Refinancing costs     0 0  
Proceeds and (repayments) from intercompany financing activities     0 0  
Purchases of treasury stock, including related fees     0 0  
Dividends from subsidiary     (126) (52)  
Dividends to parent     126 52  
Contributions from parent to subsidiary     0 0  
Stock option exercises     0 0  
Series A common stock dividends     0 0  
Preferred stock dividends     0 0  
Other, net     0 0  
Net cash provided by (used in) financing activities     0 0  
Exchange rate effects on cash and cash equivalents     0 0  
Net increase (decrease) in cash and cash equivalents     0 0  
Cash and cash equivalents at beginning of period     0 0  
Cash and cash equivalents at end of period $ 0 $ 0 $ 0 $ 0